FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Keeps Buy Opinion On Shares Of Manulife Financial Corporation

By

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target price of USD42, valuing MFC shares at 12.8x our 2026 core EPS estimate of CAD4.50 (USD3.28, converted based on the May 14, 2026 spot rate and lowered from CAD4.60/USD3.35) and at 11.8x our 2027 EPS estimate of CAD4.90 (USD3.57, lowered from CAD5.00/USD3.64), versus the stock's one-year average forward multiple of 11x and a peer average of 12x. MFC posted Q1 2026 core EPS of CAD1.06 vs. CAD0.99 prior year, compared with our CAD1.10 estimate and the CAD1.09 consensus view. Net income surged to CAD1.147B from CAD485M, due to lower market experience charges and underlying business growth. We are encouraged by these results, particularly Asia's standout performance, with core earnings up 22% to CAD820M, APE sales up 11%, and NBV up 15%, reinforcing the region as MFC's key growth engine. Currently trading at 10.5x our 2027 EPS estimate (a discount to peer and historical averages) and currently yielding 3.3%, we view the shares as undervalued.

Related Articles

Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Intel Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target price to $130 from $100, on higher revised P/E of 43.3 our 2028 EPS, as we see considerable upside to margin expectations, which share performance is typically highly correlated with. We raise our 2026 EPS estimate to $1.20 from $1.05, 2027 to $1.60 from $1.40, and keep 2028 at $3.00 (above consensus). We see considerable upside to both revenue and margin expectations (gross margin now has line of sight to over 50% by 2027/2028 vs. low 40s from the Street's forecast), as the CPU market has tightened as the shift toward greater AI inferencing/AI Agents creates a new growth opportunity for CPUs. Lead times for CPUs have extended considerably, which has also led to an upward bias to pricing that we expect to finally drive healthy gross margin expansion. Also, we expect INTC to capture more foundry orders in 2H as it demonstrates success for its internal products at leading-edge nodes, which will serve as an additional catalyst and bode well for the long-term prospects of the company.

$INTC
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Micron Technology Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target to $900 from $500, on a revised peer-discount P/E of 7.5x our CY 27 EPS of $120.00. We raise our FY 26 (Aug.) EPS estimate to $60.71 from $57.68 and FY 27 to $115.63 from $89.95. We remain confident that MU's financial position has vastly improved and see FCF of +$50B in CY 26 and +$80B in CY 27, with expected prepayments from key customers to be leveraged towards capacity expansion initiatives. We expect pricing to remain resilient well into CY 27, fueled by higher AI capex spend and the greater wafer capacity needs for high-bandwidth memory. We believe that strategic customer agreements offer better revenue visibility, and next-gen NVIDIA servers offer considerable content growth. Over time, pricing increases are likely to moderate, especially as it creates some demand destruction in cyclical markets, while our target price and assumptions conservatively assume multiples remain within the lower end of the historical range on fear of what the other end of the cycle will look like.

$MU
Research

Research Alert: CFRA Retains Hold Rating On Shares Of Brookfield Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our CAD70 applying a conservative equity risk premium and a forward P/E of 14.3x compared to the five-year historical average at 16.0x that assumes a more conservative valuation framework. We are monitoring the pace of monetization across its operating businesses and distributions to limited partners in all private funds. BN's financial results are reported in U.S. dollars and our valuation metric takes into account the foreign exchange rate of USD1 equals CAD1.37. We think BN is well positioned for 2026 growth across all businesses. We decrease our 2026 distributed earnings (DE) by USD $0.20 to USD2.90 and 2027's by USD 0.10 to USD3.50, both just below the consensus, as we assess BN's realizations from investments that impact earnings in coming quarters. In Q1 2026, cash distributions were supported by solid operating earnings in BN's infrastructure, energy, and private equity businesses. BN believes capital markets remain constructive for high-quality, cash-flowing assets, including real estate.

$BN